19-54852223-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006737.4(KIR3DL2):c.296G>A(p.Arg99His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,611,058 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIR3DL2 | NM_006737.4 | c.296G>A | p.Arg99His | missense_variant | 3/9 | ENST00000326321.7 | NP_006728.2 | |
KIR3DL2 | NM_001242867.2 | c.296G>A | p.Arg99His | missense_variant | 3/8 | NP_001229796.1 | ||
KIR3DL2 | XM_047438795.1 | c.296G>A | p.Arg99His | missense_variant | 3/7 | XP_047294751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIR3DL2 | ENST00000326321.7 | c.296G>A | p.Arg99His | missense_variant | 3/9 | 1 | NM_006737.4 | ENSP00000325525.3 | ||
KIR3DL2 | ENST00000270442.5 | c.296G>A | p.Arg99His | missense_variant | 3/8 | 1 | ENSP00000270442.5 |
Frequencies
GnomAD3 genomes AF: 0.000330 AC: 50AN: 151390Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000732 AC: 17AN: 232174Hom.: 1 AF XY: 0.0000639 AC XY: 8AN XY: 125286
GnomAD4 exome AF: 0.0000993 AC: 145AN: 1459554Hom.: 0 Cov.: 33 AF XY: 0.0000978 AC XY: 71AN XY: 726042
GnomAD4 genome AF: 0.000396 AC: 60AN: 151504Hom.: 4 Cov.: 32 AF XY: 0.000351 AC XY: 26AN XY: 74062
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at